Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Stem Cell Research

  Free Subscription


Articles published in Mol Cell

Retrieve available abstracts of 15 articles:
HTML format



Single Articles


    March 2023
  1. WU Q, Wu J, Karim K, Chen X, et al
    Massively parallel characterization of CRISPR activator efficacy in human induced pluripotent stem cells and neurons.
    Mol Cell. 2023 Mar 3:S1097-2765(23)00114-4. doi: 10.1016/j.molcel.2023.
    PubMed     Abstract available


    December 2022
  2. IANNONE C, Kainov Y, Zhuravskaya A, Hamid F, et al
    PTBP1-activated co-transcriptional splicing controls epigenetic status of pluripotent stem cells.
    Mol Cell. 2022 Dec 30:S1097-2765(22)01171-6. doi: 10.1016/j.molcel.2022.
    PubMed     Abstract available


    November 2022
  3. HU S, Metcalf E, Mahat DB, Chan L, et al
    Transcription factor antagonism regulates heterogeneity in embryonic stem cell states.
    Mol Cell. 2022 Nov 4. pii: S1097-2765(22)01022.
    PubMed     Abstract available


    September 2022
  4. JACOBS K, Doerdelmann C, Krietsch J, Gonzalez-Acosta D, et al
    Stress-triggered hematopoietic stem cell proliferation relies on PrimPol-mediated repriming.
    Mol Cell. 2022 Sep 20. pii: S1097-2765(22)00898.
    PubMed     Abstract available


    June 2022
  5. HUPPERTZ I, Perez-Perri JI, Mantas P, Sekaran T, et al
    Riboregulation of Enolase 1 activity controls glycolysis and embryonic stem cell differentiation.
    Mol Cell. 2022 Jun 10. pii: S1097-2765(22)00486.
    PubMed     Abstract available


    February 2022
  6. BARRAL A, Pozo G, Ducrot L, Papadopoulos GL, et al
    SETDB1/NSD-dependent H3K9me3/H3K36me3 dual heterochromatin maintains gene expression profiles by bookmarking poised enhancers.
    Mol Cell. 2022;82:816-832.
    PubMed     Abstract available


  7. RODRIGUEZ R, Schreiber SL, Conrad M
    Persister cancer cells: Iron addiction and vulnerability to ferroptosis.
    Mol Cell. 2022;82:728-740.
    PubMed     Abstract available


    January 2022
  8. FERGUSON CJ, Urso O, Bodrug T, Gassaway BM, et al
    APC7 mediates ubiquitin signaling in constitutive heterochromatin in the developing mammalian brain.
    Mol Cell. 2022;82:90-105.
    PubMed     Abstract available


  9. GJALTEMA RAF, Schwammle T, Kautz P, Robson M, et al
    Distal and proximal cis-regulatory elements sense X chromosome dosage and developmental state at the Xist locus.
    Mol Cell. 2022;82:190-208.
    PubMed     Abstract available


  10. SHEBAN D, Shani T, Maor R, Aguilera-Castrejon A, et al
    SUMOylation of linker histone H1 drives chromatin condensation and restriction of embryonic cell fate identity.
    Mol Cell. 2022;82:106-122.
    PubMed     Abstract available


    December 2021
  11. ORDUREAU A, Kraus F, Zhang J, An H, et al
    Temporal proteomics during neurogenesis reveals large-scale proteome and organelle remodeling via selective autophagy.
    Mol Cell. 2021;81:5082-5098.
    PubMed     Abstract available


    November 2021
  12. GOPALAN S, Wang Y, Harper NW, Garber M, et al
    Simultaneous profiling of multiple chromatin proteins in the same cells.
    Mol Cell. 2021;81:4736-4746.
    PubMed     Abstract available


  13. LIU S, Aldinger KA, Cheng CV, Kiyama T, et al
    NRF1 association with AUTS2-Polycomb mediates specific gene activation in the brain.
    Mol Cell. 2021;81:4663-4676.
    PubMed     Abstract available


  14. JAENSCH ES, Zhu J, Cochrane JC, Marr SK, et al
    A Polycomb domain found in committed cells impairs differentiation when introduced into PRC1 in pluripotent cells.
    Mol Cell. 2021;81:4677-4691.
    PubMed     Abstract available


    September 2021
  15. CONWAY E, Rossi F, Fernandez-Perez D, Ponzo E, et al
    BAP1 enhances Polycomb repression by counteracting widespread H2AK119ub1 deposition and chromatin condensation.
    Mol Cell. 2021;81:3526-3541.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Stem Cell Research is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: